公司概覽
業務類別 Medical Devices
業務概覽 NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
公司地址 Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF
電話號碼 +44 1534756700
傳真號碼 --
公司網頁 https://www.novocure.com
員工數量 1605
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael Puri Chief Human Resources Officer 美元 511.09K 26/02/2026
Dr. Uri Weinberg, M.D.,PhD Chief Medical Officer and Chief Innovation Officer 美元 541.10K 26/02/2026
Mr. Barak Ben-Arye General Counsel -- 26/02/2026
Mr. Francis Leonard Director, President; Chief Executive Officer of the Company and Subsidiary 美元 570.00K 20/04/2026
Mr. Christoph Brackmann Chief Financial Officer and Principal Accounting Officer 美元 541.10K 26/02/2026
Mr. Mukund Paravasthu Chief Operating Officer -- 26/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Martin J. Madden Independent Director 20/04/2026
Mr. William F. Doyle Executive Chairman of the Board 20/04/2026
Mr. Timothy John Scannell Independent Director 20/04/2026
Mr. Francis Leonard Director, President; Chief Executive Officer of the Company and Subsidiary 20/04/2026
Dr. David T. Hung,M.D. Independent Director 20/04/2026
Ms. Kristin Stafford, C.P.A. Independent Director 20/04/2026
Dr. Allyson J. Ocean, M.D. Independent Director 20/04/2026
Ms. Jeryl L. Hilleman Independent Director 20/04/2026
Mr. William A. Vernon Lead Independent Director 20/04/2026
Mr. Asaf Danziger Director 20/04/2026
Mr. Kinyip Gabriel Leung Independent Director 20/04/2026
 
所屬ETF (更新日期: 25/04/2026 04:02)
代號 名稱 佔比% 持有日期
IWMiShares Russell 2000 ETF2.19%31/03/2026
IWOiShares Russell 2000 Growth ETF0.74%31/03/2026
IBBiShares Biotechnology ETF0.68%31/03/2026
VTWOVanguard Russell 2000 ETF0.44%31/03/2026
SCHASchwab US Small-Cap ETF™0.44%31/03/2026
IHIiShares US Medical Devices ETF0.39%31/03/2026
VHTVanguard Health Care ETF0.28%31/03/2026
DFASDimensional US Small Cap ETF0.20%31/03/2026
BMEZBlackRock Health Sciences Term Trust0.19%31/12/2025
XHEStt Strt® SPDR® S&P®HlthCrEqpmntETF0.17%31/03/2026
ITOTiShares Core S&P Total US Stock Mkt ETF0.12%31/03/2026
NUSCNuveen ESG Small-Cap ETF0.10%31/03/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.09%31/03/2026
VTWGVanguard Russell 2000 Growth ETF0.08%31/03/2026
FYCFirst Trust Small Cap Gr AlphaDEX® ETF0.08%31/03/2026
VTVanguard Total World Stock ETF0.07%31/03/2026
HTECRobo Global® Hlthcare Tech & Innovt ETF0.06%31/03/2026
SCHBSchwab US Broad Market ETF™0.05%31/03/2026
ITEQAmplify BlueStar Israel Technology ETF0.05%31/03/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.05%31/03/2026
 1    2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.